Amedisys, Inc. (NASDAQ:AMED) Shares Acquired by Vaughan Nelson Investment Management L.P.

Vaughan Nelson Investment Management L.P. increased its holdings in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) by 4.3% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 285,803 shares of the health services provider's stock after acquiring an additional 11,670 shares during the period. Vaughan Nelson Investment Management L.P. owned about 0.88% of Amedisys worth $27,169,000 at the end of the most recent quarter.

Other large investors also recently bought and sold shares of the company. SG Americas Securities LLC boosted its holdings in Amedisys by 181.1% during the 4th quarter. SG Americas Securities LLC now owns 63,953 shares of the health services provider's stock valued at $6,079,000 after acquiring an additional 41,206 shares during the period. Bank of Nova Scotia purchased a new position in Amedisys during the 3rd quarter valued at $26,671,000. Hsbc Holdings PLC boosted its holdings in Amedisys by 184.9% during the 3rd quarter. Hsbc Holdings PLC now owns 110,479 shares of the health services provider's stock valued at $10,327,000 after acquiring an additional 71,705 shares during the period. Clear Street Markets LLC purchased a new position in Amedisys during the 3rd quarter valued at $1,252,000. Finally, UBS Group AG boosted its holdings in Amedisys by 336.5% during the 3rd quarter. UBS Group AG now owns 42,301 shares of the health services provider's stock valued at $3,951,000 after acquiring an additional 32,610 shares during the period. Hedge funds and other institutional investors own 94.36% of the company's stock.

Amedisys Stock Down 0.1 %

Shares of AMED stock traded down $0.10 during mid-day trading on Friday, hitting $92.70. The stock had a trading volume of 209,819 shares, compared to its average volume of 269,785. The firm's 50-day moving average is $93.29 and its two-hundred day moving average is $93.54. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.05 and a quick ratio of 1.05. The firm has a market capitalization of $3.03 billion, a P/E ratio of -299.02, a price-to-earnings-growth ratio of 4.36 and a beta of 0.86. Amedisys, Inc. has a 12-month low of $73.10 and a 12-month high of $96.44.

Amedisys (NASDAQ:AMED - Get Free Report) last announced its quarterly earnings data on Wednesday, February 21st. The health services provider reported $0.94 earnings per share for the quarter, missing analysts' consensus estimates of $1.04 by ($0.10). The firm had revenue of $570.79 million during the quarter, compared to analyst estimates of $566.85 million. Amedisys had a negative net margin of 0.44% and a positive return on equity of 12.76%. The firm's revenue for the quarter was up 1.6% on a year-over-year basis. During the same period in the prior year, the company posted $1.16 earnings per share. On average, analysts predict that Amedisys, Inc. will post 4.54 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities analysts recently issued reports on AMED shares. Royal Bank of Canada boosted their price objective on Amedisys from $97.00 to $100.00 and gave the company an "outperform" rating in a report on Monday, March 25th. StockNews.com initiated coverage on Amedisys in a report on Sunday, March 31st. They issued a "buy" rating for the company. Finally, Raymond James reiterated a "market perform" rating on shares of Amedisys in a report on Tuesday, March 26th. Seven equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat, Amedisys has an average rating of "Hold" and a consensus price target of $97.50.

Amedisys Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.